Risk of coronary artery disease in individuals infected with human immunodeficiency virus

Article English OPEN
Felippe Dantas Vilela; Andrea Rocha de Lorenzo, PhD in Cardiology; Bernardo Rangel Tura, PhD in Biostatistics; Giovanna Ianini Ferraiuoli; Marcelo Hadlich; Marcelo Viana de Lima Barros; Ana Beatriz Ribeiro Lima; Vanderson Meirelles;

Current treatment for human immunodeficiency virus (HIV) infection has improved survival and allowed infected patients to develop atherosclerotic coronary artery disease (CAD). Specific strategies to reduce cardiovascular risk in the infected population have not been de... View more